Cargando…
Areas of Uncertainty in SARS-CoV-2 Vaccination for Cancer Patients
Early in the COVID-19 pandemic, it was recognized that infection with SARS-CoV-2 is associated with increased morbidity and mortality in patients with cancer; therefore, preventive vaccination in cancer survivors is expected to be particularly impactful. Heterogeneity in how a neoplastic disease dia...
Autor principal: | Dimou, Anastasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784623/ https://www.ncbi.nlm.nih.gov/pubmed/36560527 http://dx.doi.org/10.3390/vaccines10122117 |
Ejemplares similares
-
Understanding the Challenges and Uncertainties of Seroprevalence Studies for SARS-CoV-2
por: McConnell, David, et al.
Publicado: (2021) -
Immunogenicity of SARS-CoV-2 vaccines in patients with cancer
por: Kakkassery, Helen, et al.
Publicado: (2022) -
Assessing Uncertainty in the Rooting of the SARS-CoV-2 Phylogeny
por: Pipes, Lenore, et al.
Publicado: (2020) -
Development of vaccines for SARS-CoV-2
por: Ng, Wern Hann, et al.
Publicado: (2020) -
SARS-CoV-2 vaccines for cancer patients: a call to action
por: Corti, Chiara, et al.
Publicado: (2021)